Effects of granulocyte colony-stimulating factor administration time on pain

被引:1
作者
Ozkaraman, A. [1 ]
Argon, G. [1 ,2 ]
Yesilbalkan, Usta O. [1 ,2 ]
Dugum, O. [1 ,3 ]
Yigitaslan, S. [1 ,4 ]
Musmul, A. [1 ,5 ]
Alparslan, Balci G. [1 ]
机构
[1] Eskisehir Osmangazi Univ, Fac Hlth Sci, Dept Nursing, Meselik Campus, TR-26480 Odunpazari, Eskisehir, Turkey
[2] Ege Univ, Fac Nursing, Izmir, Turkey
[3] Eskisehir Special Umit Batikent Hosp, Eskisehir, Turkey
[4] Eskisehir Osmangazi Univ, Fac Med, Dept Pharmacol, Eskisehir, Turkey
[5] Eskisehir Osmangazi Univ, Fac Med, Dept Biostat, Eskisehir, Turkey
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2017年 / 118卷 / 07期
关键词
cancer; G-CSF; pain; nurse; INDUCED BONE PAIN; RECEIVING CHEMOTHERAPY; CLINICAL-TRIAL; PEGFILGRASTIM; NEUTROPENIA; PREVENTION; EXERCISE; RHYTHMS;
D O I
10.4149/BLL_2017_078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: This study was aimed at evaluating the effect of administration time of granulocyte colony-stimulating factor (G-CSF) on the level of pain related to G-CSF. METHODS: This study was carried out with 48 cancer patients divided into A and B groups. In the first stage of the study, the groups A and B were planned to be administered with G-CSF at 10: 00 and 14: 00, respectively. In the second stage, patients in groups A and B were asked to self-administer filgrastim at 14: 00 and 10: 00, respectively. Patients were also asked to assess their pain level after G-CSF administration for a total of 4 times. RESULTS: According to the findings, the incidence of pain related to G-CSF was 91.7 %. The pain score after G-CSF being administered at 10: 00 was significantly higher compared to administration at 14: 00 in both groups (group A after 4, 8, and 12 hours: p < 0.05; group B after 4 and 8 hours: p < 0.05). CONCLUSIONS: The results of the present study have demonstrated that the pain score related to G-CSF administration at 14:00 p.m. was significantly reduced. Thus, in order to minimize the pain, it will be more beneficial to administer G-CSF at 14: 00 (Tab. 4, Ref. 31). Text in PDF www.elis.sk.
引用
收藏
页码:399 / 404
页数:6
相关论文
共 31 条
[1]   Bone pain from granulocyte colony stimulating factor: does clinical trial sponsorship by a pharmaceutical company influence its reporting? [J].
Aldairy, Y. ;
Nguyen, P. L. ;
Jatoi, A. .
EUROPEAN JOURNAL OF CANCER CARE, 2011, 20 (01) :72-76
[2]  
Aslan EF., 2002, J CUMHURIYET U SCH N, V6, P9, DOI DOI 10.22233/9781910443231.9
[3]   The influence of circadian rhythms on the kinetics of drugs in humans [J].
Baraldo, Massimo .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (02) :175-192
[4]  
Bellamy N, 2004, J RHEUMATOL, V31, P379
[5]   G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent [J].
Bendall, Linda J. ;
Bradstock, Kenneth F. .
CYTOKINE & GROWTH FACTOR REVIEWS, 2014, 25 (04) :355-367
[6]  
Carr J., 2012, GUIDELINE USE GRANUL
[7]  
D'Souza Anita, 2008, Transfus Med Rev, V22, P280, DOI 10.1016/j.tmrv.2008.05.005
[8]  
Dolan S., 2005, EUR J ONCOL NURS, V9, P14
[9]  
Erkekoglu P, 2012, J RES PHARM PRACT, V1, P3, DOI 10.4103/2279-042X.99670
[10]   Prevention of granulocyte-colony stimulating factor (G-CSF) induced bone pain using double histamine blockade [J].
Gavioli, Elizabeth ;
Abrams, Misty .
SUPPORTIVE CARE IN CANCER, 2017, 25 (03) :817-822